Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Kuaishou raises $2.79B for AI unit Kling AI, with Tencent investing $200M amid AI video growth.

Market News
02 Jul 2026
CNBC
View Source
Neutral
pluang ai news

Kuaishou Technology secured $2.79 billion in funding for its AI subsidiary, Kling AI, aiming for a $15 billion valuation. Tencent invested $200 million in the round, which included 21 other investors, diluting Kuaishou's stake to 68%. Kling AI focuses on AI-driven creator tools and has reached over 60 million creators globally since its June 2024 launch. This move highlights Kuaishou's push into AI video technology amid strong competition in China’s short-video market.

More News

Bitdeer sells 223.1 BTC, holds zero Bitcoin on its balance sheet, continuing full liquidation of mining output.

Bitdeer sells 223.1 BTC, holds zero Bitcoin on its balance sheet, continuing full liquidation of mining output.

Bitdeer sold 223.1 BTC this week and reported zero Bitcoin holdings on its corporate balance sheet, maintaining a strategy of fully liquidating its mined Bitcoin rather than holding it. This approach prioritizes liquidity to support operations and gr...

Market News
Neutral
4 hours ago
Revolut to delist USDT by August 31, driven by EU MiCA regulations reshaping crypto market.

Revolut to delist USDT by August 31, driven by EU MiCA regulations reshaping crypto market.

Revolut will stop supporting the stablecoin USDT on August 31, 2026, due to the European Union's new Markets in Crypto-Assets (MiCA) regulations. Users can buy USDT until July 6 and deposit until July 30, with the option to sell or transfer USDT unti...

Market News
Bearish
4 hours ago
Candel Therapeutics advances with positive Phase III prostate cancer results and strong pipeline prospects.

Candel Therapeutics advances with positive Phase III prostate cancer results and strong pipeline prospects.

Candel Therapeutics is shifting from a risky clinical-stage biotech to a late-stage oncology company, driven by its lead asset CAN-2409 which showed positive Phase III results in localized prostate cancer. Additional promising data in non-small cell ...

Analyst Insights
Bullish
4 hours ago
Paper company shows strong Q1 EBITDA and solid downside protection despite risks

Paper company shows strong Q1 EBITDA and solid downside protection despite risks

The paper company reported Q1 EBITDA slightly above expectations despite weather disruptions, supported by lower industry supply, declining imports, price increases, and better utilization rates. Conservative recovery assumptions estimate an adjusted...

Analyst Insights
Neutral
5 hours ago
MediaAlpha beats Q1 estimates with $310M revenue, strong P&C growth, and plans aggressive buybacks.

MediaAlpha beats Q1 estimates with $310M revenue, strong P&C growth, and plans aggressive buybacks.

MediaAlpha reported Q1 revenue of $310 million and adjusted EBITDA of $31.4 million, surpassing guidance due to increased participation from insurance carriers and strong growth in property and casualty (P&C) insurance. The company now generates 93% ...

Analyst Insights
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App